Point-of-care tuberculosis diagnosis: Are we there yet?

The Lancet Infectious Diseases

Volumn 12, Issue 3, 2012, Pages 169-170

  Denkinger, Claudia M ^a   Pai, Madhukar ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOARABINOMANNAN;

ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; BACTERIAL STRAIN; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; POINT OF CARE TESTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TUBERCULOSIS; URINALYSIS; WORLD HEALTH ORGANIZATION;

ANTIGENS, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MALE; POINT-OF-CARE SYSTEMS; TUBERCULOSIS, PULMONARY;

EID: 84857189322     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70257-2     Document Type: Letter

References (13)

1. Wallis RS, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375:1920-1937.
2. Batz H-G, Cooke GS, Reid SD Towards lab-free tuberculosis diagnosis (accessed Oct 7, 2011). http://www.msfaccess.org/sites/default/files/MSF_assets/TB/Docs/TB_Report_TowardsLabFreeTBDX_2011_ENG.pdf.
3. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system 2011, WHO, World Health Organization, Geneva.
4. Grenier J, Pinto LM, Nair D, et al. Widespread use of serological tests for tuberculosis: data from 22 high-burden countries. Eur Resp Journal (in press).
5. Steingart KR, Flores LL, Dendukuri N, et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med 2011, 8:e1001062.
6. Dowdy DW, Steingart KR, Pai M Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 2011, 8:e1001074.
7. Policy statement: Commercial serodiagnostic tests for diagnosis of tuberculosis 2011, WHO, World Health Organization, Geneva.
8. Flores L, Steingart K, Dendukuri N, et al. Systematic review and meta-analysis of antigen detection tests for the diagnosis of tuberculosis. Clin Vaccine Immunol 2011, 18:1616-1627.
9. Boehme C, Molokova E, Minja F, et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005, 99:893-900.
10. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. Eur Respir J 2011, published online June 23. 10.1183/09031936.00025711.
11. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 2010, 16:262-270.
12. Lawn SD, Kerkhoff AD, Vogt M, Wood R Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2011, published online October 18. 10.1016/S1473-3099(11)70251-1.
13. Peter J, Haripesad A, Mottay L, Kraus S, Meldau R, Dheda K The clinical utility of urine lipoarabinomannan and the novel point-of-care lateral flow strip test (Determine® TB) for the diagnosis of tuberculosis in hospitalised patients with HIV-related advanced immunosuppression. Am J Respir Crit Care Med 2011, 183:A5313.